UnitedHealth Surges Past S&P 500, But Investors Eye Declining ROIC

UnitedHealth Group (NYSE:UNH) has seen its stock price climb to $400.22 per share, outperforming the S&P 500 by 25.4% over the past six months with a return of 37.1%. This growth is attributed in part to the company's solid quarterly results.

The healthcare giant operates two main businesses: UnitedHealth, a health insurance provider, and Optum, which offers various healthcare services including pharmacy benefits and primary care. With over $450 billion in revenue over the past 12 months, UNH holds significant scale advantages that benefit its business model, particularly in volume-driven markets.

The company's five-year average return on invested capital (ROIC) stands at 19.2%, surpassing other healthcare companies and demonstrating effective management of growth opportunities. However, a recent decline in ROIC over the last few years has sparked caution among investors, raising questions about whether UNH's new investments will yield results.